Mutant G-protein-coupled receptors as a cause of human diseases

被引:230
|
作者
Schöneberg, T
Schulz, A
Biebermann, H
Hermsdorf, T
Römpler, H
Sangkuhl, K
机构
[1] Univ Leipzig, Fac Med, Max Planck Inst Interim, Dept Mol Biochem,Inst Biochem, D-04103 Leipzig, Germany
[2] Humboldt Univ, Otto Heubner Ctr Kinderheilkunde & Jugendmed, Berlin, Germany
关键词
diseases; G protein; receptor; signal transduction;
D O I
10.1016/j.pharmthera.2004.08.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
G-protein-coupled receptors (GPCR) are involved in directly and indirectly controlling an extraordinary variety of physiological functions. Their key roles in cellular communication have made them the target for more than 60% of all currently prescribed drugs. Mutations in GPCR can cause acquired and inherited diseases such as retinitis pigmentosa (RP), hypo- and hyperthyroidism, nephrogenic diabetes insipidus, several fertility disorders, and even carcinomas. To date, over 600 inactivating and almost 100 activating mutations in GPCR have been identified which are responsible for more than 30 different human diseases. The number of human disorders is expected to increase given the fact that over 160 GPCR have been targeted in mice. Herein, we summarize the current knowledge relevant to understanding the molecular basis of GPCR function, with primary emphasis on the mechanisms underlying GPCR malfunction responsible for different human diseases. (C) 2004 Elsevier Inc. All fights reserved.
引用
收藏
页码:173 / 206
页数:34
相关论文
共 50 条
  • [21] THE FAMILY OF G-PROTEIN-COUPLED RECEPTORS
    STRADER, CD
    FONG, TM
    GRAZIANO, MP
    TOTA, MR
    [J]. FASEB JOURNAL, 1995, 9 (09): : 745 - 754
  • [22] G-protein-coupled receptors on eosinophils
    Giembycz, MA
    Lynch, OT
    De Souza, PM
    Lindsay, MA
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2000, 13 (05) : 195 - 223
  • [23] G-protein-coupled receptors and cancer
    Robert T. Dorsam
    J. Silvio Gutkind
    [J]. Nature Reviews Cancer, 2007, 7 : 79 - 94
  • [24] G-protein-coupled receptors and their regulation - Activation of the MAP kinase signaling pathway by G-protein-coupled receptors
    Luttrell, LM
    vanBiesen, T
    Hawes, BE
    Koch, WJ
    Krueger, KM
    Touhara, K
    Lefkowitz, RJ
    [J]. SIGNAL TRANSDUCTION IN HEALTH AND DISEASE, 1997, 31 : 263 - 277
  • [25] Why are human G-protein-coupled receptors predominantly intronless?
    Gentles, AJ
    Karlin, S
    [J]. TRENDS IN GENETICS, 1999, 15 (02) : 47 - 49
  • [26] Constitutively signaling G-protein-coupled receptors and human disease
    Arvanitakis, L
    Geras-Raaka, E
    Gershengorn, MC
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1998, 9 (01): : 27 - 31
  • [27] Mechanisms of Disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases
    Andrea G Lania
    Giovanna Mantovani
    Anna Spada
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 : 681 - 693
  • [28] Mechanisms of disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases
    Lania, Andrea G.
    Mantovani, Giovanna
    Spada, Anna
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (12): : 681 - 693
  • [29] Heterotrimeric G protein activation by G-protein-coupled receptors
    Oldham, William M.
    Hamm, Heidi E.
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2008, 9 (01) : 60 - 71
  • [30] Heterotrimeric G protein activation by G-protein-coupled receptors
    William M. Oldham
    Heidi E. Hamm
    [J]. Nature Reviews Molecular Cell Biology, 2008, 9 : 60 - 71